DETAILED NOTES ON HEMGENIX

Range of suitable clients: CDEC discussed the uncertainty in the amount of individuals with reasonably extreme to extreme hemophilia B in Canada suitable for etranacogene dezaparvovec. Scientific experts consulted by CADTH indicated that some people that are labeled as obtaining gentle or average disease could have a intense bleeding phenotype, whi